Table 3.
Ocular side effects and treatment.
| Variable | Number of cases | Percent |
|---|---|---|
| Side effects | ||
| Uveitis (anterior, posterior, panuveitis) | 9 (7, 1, 1) | 40.9 (77.8, 11.1, 11.1) |
| Dry eye | 5 | 22.7 |
| CSR-like | 5 | 22.7 |
| Vitreitis | 2 | 9.1 |
| CRAO | 1 | 4.5 |
| CME | 1 | 4.5 |
| Trichomegaly | 3 | 13.6 |
| BRVO | 1 | 4.5 |
| Treatment | ||
| Intravitreal bevacizumab injection | 1 | 4.5 |
| Intravitreal Kenalog injection | 2 | 9.00 |
| Topical | ||
| Artificial tears | 5 | 22.5 |
| Steroids | 9 | 40.5 |
| Pupil dilator | 7 | 31.5 |
| Oral therapy—prednisone | 9 | 40.5 |
| Surgical—pars plana vitrectomy | 1 | 4.5 |
CSR, central serous retinopathy; CRAO, central retinal artery occlusion; CME, cystoid macular edema; BRVO, branch retinal vein occlusion.